ERBB2放大是具有异质HER2表达的高度子宫内膜癌的发病过程中的晚期事件
Michael Herman Chui1, David N Brown1, Jorge S Reis-Filho1
1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
The Journal of pathology
|January 7, 2026
概括
高度子宫内膜癌中HER2异质性在瘤进化晚期出现,这表明ERBB2放大驱动进展而不是启动. 这一发现影响了对抗HER2治疗耐药性的理解.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子病理学分子病理学
背景情况:
- 在高度子宫内膜癌 (HG-EC) 中,ERBB2放大/HER2过度表达的内异质性很常见.
- 这种异质性有助于抵抗抗HER2疗法.
- 了解HER2异质性的分子基础对于开发有效的治疗方法至关重要.
研究的目的:
- 研究HER2-异质HG-ECs的分子病原和进化轨迹.
- 为了识别导致HER2异质性的遗传变化.
- 探索ERBB2放大在瘤进化和进展中的作用.
主要方法:
- 空间上不同的HER2-阴性和HER2-阳性瘤区域的下一代测序 (整个外体和向面板).
- 对体突变和副本数量改变的分析.
- 全基因组复制号数据的无监督层次聚类.
- 探索性的空间转录学.
主要成果:
- HER2-和HER2+组件共享了大多数体质突变,位于17q12安普利康的ERBB2基因是关键的差异化因素.
- 按患者分组的瘤样本,而不是根据HER2状态,表明共享的克隆起源.
- 在初级和转移性病变中观察到HER2异质性,这表明从不同的亚种群进化.
- 空间转录组学表明,在某些情况下,HER2+区域的表皮分化向表皮分化转移.
结论:
- 在HG-EC中HER2异质性可能是由于在瘤进化过程中晚期获得ERBB2放大.
- 在这些瘤中,ERBB2放大似乎在瘤进展中起作用,而不是启动.
- 研究结果表明,ERBB2在已建立的瘤进展中具有上下文依赖的作用,影响治疗耐药性.
更多相关视频
03:55Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens
Published on: July 12, 2024
2.1K
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
674
相关概念视频
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
01:20The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:15Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K